# data[].attributes.body
As an ICU RN, I can visualize this device being used in the hospital upon patient's arrival to the ER, throughout hospital admission, and discharge.

I believe that BioSticker can be used in inpatient or outpatient settings by doctors, nurses, physical therapists, and occupational therapists. The data will be available to the multidisciplinary care team to formulate an appropriate care plan for the patient.

This device can improve patient safety measures, reduce healthcare costs, decrease healthcare use, decrease hospital readmission, and increase physician involvement (PR Newswire, 2020).

# data[].attributes.body
Alice, Amelia, Izzie, Matthew, and Rachel

# data[].attributes.attachment_link.readable_text
"We are at the inception of a remarkable new era in healthcare that will employ medical grade sensor technologies to effortlessly capture remote patient data and generate personalized clinical intelligence," said James Mault, MD, FACS, CEO of BioIntelliSense.

The BioSticker is an advanced on-body sensor that allows for effortless continuous monitoring of vital signs and actionable insights, delivered to clinicians from patients in the home setting, thereby creating unique opportunities for early detection of potentially avoidable complications. Through the platform's data sets and analytics, highly-efficient care is now possible at a fraction of the cost of traditional remote patient monitoring.

BioIntelliSense is built on the foundation of a sophisticated team of engineers and data scientists with decades of expertise in wearable sensor development. With these distinctive capabilities and proprietary technologies, the company is poised to help transform care delivery under the leadership of Dr. Mault, an industry veteran who has an accomplished business and clinical career that has culminated in a number of successful connected health ventures.

BioIntelliSense has established a strategic collaboration with UCHealth and its CARE Innovation Center to demonstrate the value and clinical applications of the BioSticker device and medical-grade services. This alliance is committed to developing and validating new models of data-driven care that are patient-centered and built for scale.

"The future of healthcare will see the lines blurred between the hospital, clinic and home," said Dr. Richard Zane, UCHealth Chief Innovation Officer and Chair of Emergency Medicine at the University of Colorado School of Medicine. "The use of the BioSticker device for continuous health monitoring enables us to monitor a patient in their home and recognize when a patient may have an exacerbation of illness even before they manifest symptoms. This may reduce hospitalizations, emergency department visits and shorten hospital stays, creating cost efficiencies for health systems."

"We are proud and excited to be working with the innovative teams at UCHealth and the University of Colorado Anschutz Medical Campus," Dr. Mault said. "It is a remarkable collaboration and clinical proving ground for our continuous monitoring and predictive data services platform. UCHealth has made it possible for BioIntelliSense to rapidly accelerate the development of our technology, as well as optimize its clinical validation."

About BioIntelliSense
BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM). Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures minute-to-minute vital signs, physiological biometrics and symptomatic events through an effortless patient experience. The FDA-cleared BioSticker™ device makes remote monitoring and early detection simple. Through the platform's advanced analytics, clinicians will now have access to high-resolution patient trending and reporting to enable medical grade care in the home.

For more information on how BioIntelliSense is redefining remote patient monitoring through medical-grade and cost-effective data services, please contact us at [email protected] or visit our website at BioIntelliSense.com.

SOURCE BioIntelliSense, Inc.

Related Links

https://biointellisense.com

# data[].attributes.attachment_link.title
BioIntelliSense Announces FDA Clearance of the BioSticker™, the First Single-Use Medical Device Enabling 30 Days of Continuous Vital Signs Monitoring

# data[].attributes.attachment_link.description
"We are at the inception of a remarkable new era in healthcare that will employ medical grade sensor technologies to effortlessly capture remote patient data and generate personalized clinical intelligence," said James Mault, MD, FACS, CEO of BioIntelliSense.

# data[].attributes.body
January 28, 2020

# data[].attributes.body
The FDA approved a product by BioIntelliSense, Inc. called BioSticker (Medgadget Editors, 2020).

BioIntelliSense, Inc. is founded by Dr. James Mault and David Wang to help transform care delivery. The company's collaboration with the University of Colorado Health and its CARE Innovation Center demonstrates the value, clinical applications, and commitment to developing and validating data-driven care models that are patient-centered and built for scale (PR Newswire, 2020).

# data[].attributes.body
effortless user experience

remote monitoring

continuous prognostication of patient health status

convenient product size

cost-effective at $145 per sticker.

proactive safety monitoring

patient-centered approach

earlier discharge of patients hospitalized

decrease hospital admission and readmission

(BioIntelliSense, 2020)

# data[].attributes.body
the risk for a data breach

signal interference

unknown if health insurance coverage is available for a new device

no material details provided regarding water contact (waterproof)

refill cost of each additional device if monitoring exceeds more than 1 month

# data[].attributes.body
An FDA-cleared, single-use, and medical-grade device to continuously monitor vital signs for up to 30 days.

Respiratory rate, heart rate at rest, and skin temperature

Body position, steps and activity levels, sleep status

High-resolution gait analysis and fall detection

Symptomatic events

It is designed to be worn on the upper left chest for effortless remote data capture and a simplistic “stick it on and forget it” patient experience.

(BioIntelliSense, 2020)

# data[].attributes.attachment_link.title
Your Healthy Family: Innovative bio-sticker will monitor patients’ vital signs from their home

# data[].attributes.body
BioSticker can be used to confidently and safely initiate early discharge of patients hospitalized with COVID-19 to expand bed
capacity for new COVID-19 patients requiring admission (Care Kinesis, 2020).

# data[].attributes.body
BioIntelliSense, Inc. (2020). BioSticker. Retrieved September 25, 2020, from https://biointellisense.com/#overview

Care Kinesis. (2020). Remote patient monitoring and hospital at home for COVID-19. BioIntelliSense, Inc. Retrieved September 25, 2020, from http://www.carekinesis.com/wp-content/uploads/BioIntelliSense-Slides-12March2020.pdf

KOAA News5. (2020). Innovative bio-sticker will monitor patients’ vital signs from their home. Your Healthy Family. Retrieved from https://www.youtube.com/watch?v=JVM4f0rCamo#action=share

Medgadget Editors. (2020). BioSticker FDA cleared for month-long vitals monitoring. Medgadget. Retrieved September 25, 2020, from https://www.medgadget.com/2020/02/biosticker-fda-cleared-for-month-long-vitals-monitoring.html

PR Newswire. (2020). BioIntelliSense: Announces FDA clearance of the BioSticker, the first single-use medical device enabling 30 days of continuous vital signs monitoring. Retrieved September 25, 2020, from https://www.prnewswire.com/news-releases/biointellisense-announces-fda-clearance-of-the-biosticker-the-first-single-use-medical-device-enabling-30-days-of-continuous-vital-signs-monitoring-300994129.html

# data[].attributes.body
Dr. James Mault is a board-certified in General Surgery and Cardiothoracic Surgery specializing in heart and lung transplantation, thoracic oncology, and critical care. He has more than 35 years of experience in health IT, the medical device industry, and clinical medicine.

David Wang is a computer and electrical engineer with 20 years of experience in product execution and innovation.

The University of Colorado Health is a teaching hospital; nationally ranked in 9 adult specialties specialties and rated high performing in 2 adult specialties and 6 procedures and conditions.

(BioIntelliSense, 2020)

# data[].attributes.body
Strength: Achiever

She is energetic with a strong work ethic to help us with productivity.

# data[].attributes.body
Strengths: Adaptability

She is flexible, easygoing, and adaptable to assist the team and customers, especially when issues arise.

# data[].attributes.body
Strength: Input

He is knowledgeable, detail-oriented, and a great resource about the product to the team and customers.

# data[].attributes.body
Strength: Maximizer

He is vital in transforming, improving, and stimulating personal, group, and product excellence.

# data[].attributes.body
Strength: Restorative

She is a problem solver and a great resource to the team and customers on issues, improvements, and solutions.